Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
"Yin Yang" Principle Suggests New Approach To Evaluating Breast Cancer Treatments
http://www.medicalnewstoday.com/articles/129430.php
About six in 10 breast cancer cases are caused when estrogen triggers cell receptors to promote abnormal cell growth leading to tumors. But if two particular receptors come together in what a University of Wisconsin-Madison researcher calls a "yin yang" relationship, one might knock down the activity of the other and breast cancer growth could be halted.
Fighting Breast Cancer With "Two-Headed" Antibody
http://www.medicalnewstoday.com/articles/129419.php
A small, antibody-like molecule created by researchers at Fox Chase Cancer Center can successfully attack two separate molecules on the surface of cancer cells at the same time, halting the growth of breast cancer cells in laboratory tests, the researchers say.
Study Finds No Breast Cancer Reduction From Calcium, Vitamin D Supplements
http://www.medicalnewstoday.com/articles/129371.php
<BR>Women who took vitamin D and calcium supplements developed breast cancer at the same rate as those who did not take the supplements, according to a <A href="http://jnci.oxfordjournals.org/cgi/content/abstract/djn360" target=_new>study</A> by the <A href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
Identification Of Molecule Linked To Aggressive Cancer Growth, Spread
http://www.medicalnewstoday.com/articles/129466.php
<b>The finding:</b> Researchers at the University of Michigan Comprehensive Cancer Center have found a genetic marker that controls an enzyme present in aggressive and metastatic cancer. The study suggests an absence of microRNA-101 is related to high expression of the protein EZH2, which was previously shown to be active in metastatic cancers.
Combined Technologies Facilitate The Rapid Discovery Of New Genes That Lead To Cancer
http://www.medicalnewstoday.com/articles/129463.php
Using a new approach that combines scientific technologies to hunt down genetic changes involved in cancer, researchers have discovered 13 tumor suppressor genes that, when mutated, can lead to liver cancers.
Oslo And Toulouse Cancer Clusters Join Forces To Drive European Cancer Research Forward
http://www.medicalnewstoday.com/articles/129445.php
Oslo Cancer Cluster today signed a groundbreaking strategic agreement with the Toulouse Cancéropole and Cancer-Bio-Santé Cluster which will lead to an integrated effort to become the leading cancer centers in Europe for developing new cancer therapies.
Cancer Treatment May Result In Bone Loss - New Cross Canada Study
http://www.medicalnewstoday.com/articles/129434.php
A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the <i>American Society of Clinical Oncology,</i> the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.
Fighting Breast Cancer With "Two-Headed" Antibody
http://www.medicalnewstoday.com/articles/129419.php
A small, antibody-like molecule created by researchers at Fox Chase Cancer Center can successfully attack two separate molecules on the surface of cancer cells at the same time, halting the growth of breast cancer cells in laboratory tests, the researchers say.
"Jet Injection" For Gene Therapy - First Clinical Trial Evaluates Feasibility
http://www.medicalnewstoday.com/articles/129415.php
For the first time in a clinical study, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and the Charité - Universitätsmedizin Berlin, Germany, have tested a new technology enabling them to transfer genetic material directly into a tumor by means of high pressure.
How Cancer Progression Can Be Spurred By Eating Red Meat
http://www.medicalnewstoday.com/articles/129413.php
Researchers at the University of California, San Diego School of Medicine, led by Ajit Varki, M.D., have shown a new mechanism for how human consumption of red meat and milk products could contribute to the increased risk of cancerous tumors.
Melanoma Research Claims French Science Prize
http://www.medicalnewstoday.com/articles/129404.php
She's travelled between Brisbane and Paris to better understand skin cancer, and now UQ PhD student Marina Kvaskoff has been awarded a top French prize for her research. Ms Kvaskoff, from St Lucia, is one of only 10 academics to win a 2008 L'Oreal France-UNESCO For Women in Science Award, with the prizes presented in Paris next week.
Stop Skin Cancer On The Spot: New Tools Aid In Diagnosing And Detecting Skin Cancer In Earliest Stages
http://www.medicalnewstoday.com/articles/129338.php
Based on current estimates, 8,420 people are expected to die from melanoma this year. In an effort to reverse this sobering trend, dermatologists and the scientific community alike are continually developing new diagnostics, refining detection guidelines and providing patients with the tools they need to properly examine their own skin for signs of skin cancer.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Modelling Research Shows CervarixTM-induced Immune Response May Be Prolonged For At Least 20 Years For Both HPV 16 And 18
http://www.medicalnewstoday.com/articles/129457.php
Results of three statistical models presented today at the European Research Organisation on Genital Infection and Neoplasia (EUROGIN) annual meeting in Nice, France, suggest that young women vaccinated with GlaxoSmithKline's cervical cancer vaccine CervarixTM could look forward to a prolonged immune response against the two most common cancer-causing human papillomavirus virus (HPV) types, HPV 16 and 18 for at least 20 years.
Study Finds HPV Vaccine Gardasil Effective At Preventing Male Genital Lesions
http://www.medicalnewstoday.com/articles/129370.php
<BR>Merck's human papillomavirus vaccine Gardasil is about 90% effective in preventing external lesions -- mostly gential warts -- caused by the four HPV strains it targets and 45% effective in preventing HPV infection, according to a Merck-funded study, <A href="http://www.
Hologic Releases The Results Of The Cervista(TM) HPV Clinical Trials
http://www.medicalnewstoday.com/articles/129323.php
Hologic, Inc. (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the results of the Cervista HPV high-risk pivotal clinical trial.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
In Determining Overall Survival Of Lung Cancer Patients, Gender Is Key
http://www.medicalnewstoday.com/articles/129479.php
Even though some combinations of gender, race and/or marital statuscan factor into the overall survival of nonoperative non-small cell lung cancer patients, gender is the mostsignificant factor impacting overall survival, according to a study presented at the 2008 ChicagoMultidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the Universityof Chicago.
Proton Therapy May Reduce Serious Side Effect Of Lung Cancer Treatment
http://www.medicalnewstoday.com/articles/129478.php
Patients with locally advanced lung cancer who receive chemotherapyand proton therapy, a specialized form a radiation therapy only available in a few centers in the United States,have fewer instances of a serious side effect called bone marrow toxicity than patients who receivechemotherapy and another type of radiation therapy called intensity modulated radiation therapy (IMRT),according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology,sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
Research Demonstrating Differing Genetic Makeup Of Lung Cancer In AfricanAmerican Patients Informs Clinical Development Of EGFR Inhibitor Drugs
http://www.medicalnewstoday.com/articles/129476.php
The tumors of African-American non-small cell lung cancer patients aremore likely to carry a higher number of copies of the epidermal growth factor receptor (EGFR) gene and fewermutations of EGFR itself than Caucasians according to a study presented at the 2008 Chicago MultidisciplinarySymposium in Thoracic Oncology, cosponsored by ASTRO, ASCO, IASLC and the University of Chicago.
Study First To Combine 2 Chemotherapies And 2 Targeted Therapies
http://www.medicalnewstoday.com/articles/129460.php
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M.
Overall Survival In 1st-line NSCLC Reaches 15 Months With Erbitux, Merck Serrono Informs
http://www.medicalnewstoday.com/articles/129442.php
Data presented today at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology show that patients with non-small cell lung cancer (NSCLC) who were given Erbitux® (cetuximab) in addition to a standard 1st-line platinum-based chemotherapy lived significantly longer than those who received chemotherapy alone.
Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent Chemotherapy
http://www.medicalnewstoday.com/articles/129420.php
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment